Lack of association between paraoxonase-1 Q192R polymorphism and rheumatoid arthritis in southeast Iran

被引:76
作者
Hashemi, M. [1 ,2 ]
Moazeni-Roodi, A. K. [3 ]
Fazaeli, A. [4 ]
Sandoughi, M. [5 ]
Bardestani, G. R. [5 ]
Kordi-Tamandani, D. M. [3 ]
Ghavami, S. [6 ]
机构
[1] Zahedan Univ Med Sci, Sch Med, Dept Clin Biochem, Zahedan, Iran
[2] Zahedan Univ Med Sci, Cellular & Mol Res Ctr, Zahedan, Iran
[3] Sistam & Baluchistan Univ, Fac Sci, Dept Biol, Zahedan, Iran
[4] Zanjan Univ Med Sci, Sch Med, Dept Parasitol, Zanjan, Iran
[5] Zahedan Univ Med Sci, Sch Med, Dept Internal Med, Zahedan, Iran
[6] Univ Manitoba, Dept Physiol, Manitoba Inst Child Hlth, Winnipeg, MB, Canada
来源
GENETICS AND MOLECULAR RESEARCH | 2010年 / 9卷 / 01期
关键词
Paraoxonase; PON1; Q192R polymorphism; Rheumatoid arthritis; HIGH-DENSITY-LIPOPROTEIN; SERUM PARAOXONASE; ALZHEIMERS-DISEASE; REACTIVE OXYGEN; ARYLESTERASE; ESTERASE; SYSTEM; PON1; OXIDATION; DECREASE;
D O I
10.4238/vol9-1gmr728
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Decreased paraoxonase-1 (PON1) activity has been associated with rheumatoid arthritis. There are two polymorphisms in serum PON1; one differs in the amino acid at position 192 (Q192R) and the other one differs at position 55 (L55M). We looked for a possible association between Q192R polymorphism and rheumatoid arthritis. The Q192R polymorphism in 88 rheumatoid arthritis patients and 78 healthy subjects was determined using tetra amplification refractory mutation system-polymerase chain reaction (ARMS-PCR) and PCR-restriction fragment length polymorphism (RFLP) methods. We found no significant differences between rheumatoid arthritis patients and control subjects regarding PON1 Q192R polymorphism. PON1 Q192R polymorphism was not found to be correlated with increased risk for rheumatoid arthritis in this Iranian population.
引用
收藏
页码:333 / 339
页数:7
相关论文
共 35 条
  • [1] Agrawal S, 2009, Indian J Med Sci, V63, P335, DOI 10.4103/0019-5359.55884
  • [2] Rapid genomic DNA extraction (RGDE)
    Ali, Saremi Mohammad
    Mahnaz, Saremi
    Mahmood, Tavallaei
    [J]. FORENSIC SCIENCE INTERNATIONAL GENETICS SUPPLEMENT SERIES, 2008, 1 (01) : 63 - 65
  • [3] THE AMERICAN-RHEUMATISM-ASSOCIATION 1987 REVISED CRITERIA FOR THE CLASSIFICATION OF RHEUMATOID-ARTHRITIS
    ARNETT, FC
    EDWORTHY, SM
    BLOCH, DA
    MCSHANE, DJ
    FRIES, JF
    COOPER, NS
    HEALEY, LA
    KAPLAN, SR
    LIANG, MH
    LUTHRA, HS
    MEDSGER, TA
    MITCHELL, DM
    NEUSTADT, DH
    PINALS, RS
    SCHALLER, JG
    SHARP, JT
    WILDER, RL
    HUNDER, GG
    [J]. ARTHRITIS AND RHEUMATISM, 1988, 31 (03): : 315 - 324
  • [4] Human serum paraoxonases (PON1) Q and R selectively decrease lipid peroxides in human coronary and carotid atherosclerotic lesions - PON1 esterase and peroxidase-like activities
    Aviram, M
    Hardak, E
    Vaya, J
    Mahmood, S
    Milo, S
    Hoffman, A
    Billicke, S
    Draganov, D
    Rosenblat, M
    [J]. CIRCULATION, 2000, 101 (21) : 2510 - 2517
  • [5] Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions - A possible peroxidative role for paraoxonase
    Aviram, M
    Rosenblat, M
    Bisgaier, CL
    Newton, RS
    Primo-Parmo, SL
    La Du, BN
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (08) : 1581 - 1590
  • [6] Assessment of paraoxonase 1 activity and malondialdehyde levels in patients with rheumatoid arthritis
    Baskol, G
    Demir, H
    Baskol, M
    Kilic, E
    Ates, F
    Kocer, D
    Muhtaroglu, S
    [J]. CLINICAL BIOCHEMISTRY, 2005, 38 (10) : 951 - 955
  • [7] Bauerová K, 1999, GEN PHYSIOL BIOPHYS, V18, P15
  • [8] IDENTIFICATION OF A DISTINCT HUMAN HIGH-DENSITY-LIPOPROTEIN SUBSPECIES DEFINED BY A LIPOPROTEIN-ASSOCIATED PROTEIN, K-45 - IDENTITY OF K-45 WITH PARAOXONASE
    BLATTER, MC
    JAMES, RW
    MESSMER, S
    BARJA, F
    POMETTA, D
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1993, 211 (03): : 871 - 879
  • [9] THE FAMILIAL NATURE OF RHEUMATOID-ARTHRITIS
    DEIGHTON, CM
    WALKER, DJ
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 1991, 50 (01) : 62 - 65
  • [10] Paraoxonase activity in the serum and hepatic mRNA levels decrease during the acute phase response
    Feingold, KR
    Memon, RA
    Moser, AH
    Grunfeld, C
    [J]. ATHEROSCLEROSIS, 1998, 139 (02) : 307 - 315